Cure from severe aplastic anemia in vivo and late effects

Acta Haematologica

Volumn 103, Issue 1, 2000, Pages 49-54

  Socié, Gérard ^a   Gluckman, Eliane ^a  

^a SAINT LOUIS HOSPITAL   (France)

Author keywords

Aplastic anemia; Long term survival; Secondary malignancies

Indexed keywords

AZATHIOPRINE; CYCLOPHOSPHAMIDE; CYCLOSPORIN; GRANULOCYTE COLONY STIMULATING FACTOR; IMMUNOSUPPRESSIVE AGENT; LYMPHOBLAST ANTIBODY;

APLASTIC ANEMIA; BONE MARROW TRANSPLANTATION; DISEASE COURSE; GRAFT VERSUS HOST REACTION; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; LEUKEMIA; MONOSOMY 7; MYELODYSPLASTIC SYNDROME; PRIORITY JOURNAL; REVIEW; SOLID TUMOR;

EID: 0034018217     PISSN: 00015792     EISSN: None     Source Type: Journal    
DOI: 10.1159/000041004     Document Type: Review

References (22)

1. Schrezenmeier H, Hildebrand A, Rojewski M, Häcker H, Heimpel H, Raghavachar A: Paroxysmal nocturnal haemoglobinuria: A replacement of haematopoietic tissue? Acta Haematol 2000;103:41-48.
2. De Planque MM, Kluinnelemans HC, Van Krieken HJ, Kluin PM, Brand A, Beverstock GC, et al: Evolution of acquired severe aplastic anaemia to myelodysplastic and subsequent leukemia in adults. Br J Haematol 1989;70:55-61.
3. Tichelli A, Gratwohl A, Wursch A, Nissen C, Speck B: Late haematological complications in severe aplastic anaemia. Br J Haematol 1988; 69:413-418.
4. Tichelli A, Gratwohl A, Nissen C, Speck B: Late clonal complications in severe aplastic anemia. Lenk Lymphoma 1994;12:167-175.
5. De Planque MM. Bacigalupo A, Wursch A, Hows J, Devergie A, Frickhofen N, et al: Long-term follow-up of severe aplastic anaemia patients treated with antilymphocyte globulin. Br J Haematol 1989;73:121-126.
6. Paquette RL, Tebyani N, Frane M, Ireland P, Ho WG, Champlin RE, et al: Long-term outcome of aplastic anemia in adults treated with antithymocyte globulin: Comparison with bone marrow transplantation. Blood 1995;85: 283-290.
7. Doney K, Leisenring W, Storb R, Appelbaum FR: Primary treatment of acquired aplastic anemia: Outcomes with bone marrow transplantation and immunosuppressive therapy. Ann Intern Med 1997;126:107-115.
8. Socie G, Henryamar M, Bacigalupo A, Hows J, Tichelli A, Ljungman P, et al: Malignant tumors occurring after treatment of aplastic anemia. N Engl J Med 1993;329:1152-1157.
9. Ohara A, Kojima S, Hamajima N, Tsuchida M, Imashuku S, Ohta S, et al: Myelodysplastic syndrome and acute myelogenous leukemia as a late clonal complication in children with acquired aplastic anemia. Blood 1997;90:1009-1013.
10. Kaito K, Kobayashi M, Katayama T, Masuoka H, Shimada T, Nishiwaki K, et al: Long-term administration of G-CSG for aplastic anaemia is closely related to the early evolution of monosomy 7 MDS in adults. Br J Haematol 1998; 103:297-303.
11. Bacigalupo A, Broccia G, Corda G, Arcese W, Carotenuto M, Gallamini A, et al: Antilymphocyte globulin, cyclosporin, and granulocyte colony-stimulating factor in patients with acquired severe aplastic anemia (SAA): A pilot study of the EBMT SAA Working Party. Blood 1995;85:1348-1353.
12. Rosenfeld SJ, Kimball J, Vining D, Young NS: Intensive immunosuppression with antithymocyte globulin and cyclosporine as treatment for severe acquired aplastic anemia. Blood 1995; 85:3058-3065.
13. Frickhofen N, Schrezenmeier H, Bacigalupo A: Results of European trials of immunosuppression for treatment of aplastic anemia; in Gluckman E, Coulombel L (eds): Ontogeny of Hematopiesis, Aplastic Anemia. Libbey Eurotext 1995, pt 5: Treatment of aplastic anemia, pp 335-345.
14. Deeg HJ, Leisenring W, Storb R, Nims J, Flowers MED, Witherspoon RP, et al: Long-term outcome after marrow transplantation for severe aplastic anemia. Blood 1998;91:3637-3645.
15. Browne PV, Lawler M, Humphries P. McCann SR: Donor-cell leukemia after bone marrow transplantation for severe aplastic anemia. N Engl J Med 1991;325:710-713.
16. Appelbaum F, Barrall J, Storb R, Ramberg R, Doney K, Sale G, et al: Clonal cytogenetic abnormalities in patients with otherwise typical aplastic anemia. Exp Hematol 1987;15: 1134-1139.
17. Mikhailova N, Sessarego M, Fugazza G, Caimo A, Defilippi S, Vanlint MT, et al: Cytogenetic abnormalities in patients with severe aplastic anemia. Haematologica 1996;81:418-422.
18. Yamazaki E, Kanamori H, Taguchi J, Harano H, Mohri H, Okubo T: The evidence of clonal evolution with monosomy 7 in aplastic anemia following granulocyte colony-stimulating factor using the polymerase chain reaction. Blood Cells Mol Dis 1997;23:213-218.
19. Socié G, Henryamar M, Cosset JM, Devergie A, Girinski T, Gluckman E: Increased incidence of solid malignant tumors after bone marrow transplantation for severe aplastic anemia. Blood 1991;78:277-279.
20. Witherspoon RP, Storb R, Pepe M, Longton G, Sullivan KM: Cumulative incidence of secondary solid malignant tumors in aplastic anemia given marrow grafts after conditioning with chemotherapy alone. Blood 1991;79:289-291.
21. Deeg HJ, Socié G, Schoch G, Henryamar M, Witherspoon RP, Devergie A, et al: Malignancies after marrow transplantation for aplastic anemia and Fanconi anemia: A joint Seattle and Paris analysis of results in 700 patients. Blood 1996;87:386-392.
22. Marsh JCW, Zomas A, Hows JM, Chapple M, Gordonsmith EC: Avascular necrosis after treatment of aplastic anaemia with antilymphocyte globulin and high-dose methylprednisolone. Br J Haematol 1993;84:731-735.